Raymond Joseph Tesi
President and CEO at INmune Bio Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: INmune Bio Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
INmune Bio Inc. June 10, 202595.2%
-
INmune Bio Inc. July 19, 202495.1%
-
INmune Bio Inc. June 1, 202394.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 12, 2024 | INmune Bio Inc. | Open-market purchase | +15,380 | $6.38 | $98,124 |
| Apr 19, 2024 | INmune Bio Inc. | Grant or award | +18,028 | $8.32 | $149,993 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.